Bringing the fundamentals into focus…
Back to REGENXBIO Inc.
How REGENXBIO Inc. stacks up
RGNX · against 1,216 other Healthcare companies
Growth
69/ 100
Above the middle of the pack.
Ranked #372 of 1,217 · scores higher than 69% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 60–69, including RGNX · Click a bar to see the companies
Why growth scores 69?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 66% of peers. Revenue growth: 12.0% vs peer median 6.1%
- faster revenue growth over three years: stronger than 82% of peers. 3-year revenue growth: 21.6% vs peer median 5.8%
Metric by metric
Position: dot = RGNX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RGNX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 12.0% | 6.1% | 66% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 21.6% | 5.8% | 82% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around RGNX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 372 | 14.3B TRY (≈$428M) | 69 | 60 | |
| 372 | 116.5B USD | 69 | 57 | |
| 372 | 4.0B USD | 69 | 56 | |
| 372 | 37M GBP (≈$48M) | 69 | ||
| 372 | 504M USD | 69 | 24 | |
| 372 | 49.1B USD | 69 | 69 | |
| 385 | 585.5B KRW (≈$422M) | 68 | 63 | |
| 385 | 8.0B CNY (≈$1.1B) | 68 | 58 | |
| 385 | 83.8B KRW (≈$60M) | 68 | 54 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score